Akili, Inc. announced the appointment of Mary Hentges to the company's board of directors, effective October 25, 2022. Hentges will serve as chair of the Audit Committee and a member of the Compensation Committee. Mary has extensive executive-level and financial experience with both public and private companies.

Hentges' proven track record serving as chief financial officer at several high-growth companies will support Akili as it enters its next phase of growth with the commercialization of its product, EndeavorRx. Hentges has held the roles of interim CFO at ShotSpotter, Inc., a precision-policing solutions company; CFO of YapStone, Inc., a digital payments provider; CFO of CBS Interactive, an internet media company; and CFO of PayPal, Inc., a global digital financial services provider. Prior to those positions, Hentges worked in a variety of roles in finance at Agilent Technologies, Inc., and Hewlett-Packard, Inc., diversified technology companies.

Additionally, Hentges holds several board positions, including director and audit committee member, Upstart Holdings, Inc; director and finance committee chair, nominating and governance committee member and executive committee member, Kaiser Permanente Bernard J. Tyson School of Medicine; and director and investment committee member, ASU Foundation. Hentges joins the company's current board members William (BJ) Jones, chief commercial officer of Biohaven Pharmaceuticals; Christine Lemke, co-chief executive officer and a director of Evidation Health; Ken Ehlert, former chief scientific officer at UnitedHealth Group; Adam Gazzaley, M.D., Ph.D., co-founder of Akili and founding director of Neuroscape at UCSF; Eddie Martucci, Ph.D., co-founder and CEO of Akili; and Chamath Palihapitiya, founder and CEO of Social Capital and chairman and managing partner of Social Capital Suvretta Holdings, who serves as chair of the company's board.